NDC 68083-479
Lincomycin hydrochloride
Lincomycin Hydrochloride
Lincomycin hydrochloride is a Intramuscular; Intravenous; Subconjunctival Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Gland Pharma Limited. The primary component is Lincomycin Hydrochloride.
| Product ID | 68083-479_084e1826-51be-4e48-aae4-b6affb80853f |
| NDC | 68083-479 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Lincomycin hydrochloride |
| Generic Name | Lincomycin Hydrochloride |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAMUSCULAR; INTRAVENOUS; SUBCONJUNCTIVAL |
| Marketing Start Date | 2022-09-26 |
| Marketing Category | ANDA / |
| Application Number | ANDA215657 |
| Labeler Name | Gland Pharma Limited |
| Substance Name | LINCOMYCIN HYDROCHLORIDE |
| Active Ingredient Strength | 300 mg/mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |